ArticleDiagnostics (Basel, Switzerland)2022

Evaluation of CD44s, CD44v6, CXCR2, CXCL1, and IL-1β in Benign and Malignant Tumors of Salivary Glands.

Fonthip Laohavisudhi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.